According to Rigel Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -โน0.55 B. In 2023 the company made an earning of -โน1.53 B an increase over its 2022 earnings that were of -โน4.61 B.The earnings displayed on this page is the company's Pretax Income.